跳至主要内容
临床试验/NCT06140147
NCT06140147招募中不适用

Protocolized Reduction of Non-resuscitation Fluids Versus Usual Care in Septic Shock Patients

Region Skane28 个研究点 分布在 3 个国家目标入组 1,850 人开始时间: 2023年11月27日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Region Skane
入组人数
1,850
试验地点
28
主要终点
Mortality

研究概览

简要总结

The objective of this trial is to assess the beneficial and harmful effects of a restrictive strategy for administration of non-resuscitation fluids in adult patients with septic shock.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

The clinical team caring for participants will not be blinded due to the nature of the intervention. The participants and their family will not be actively informed about group allocation. The steering group, author group, trial statistician, outcome assessors, prognosticators, the trial coordinating team, manuscript writers and the data safety and monitoring committee will be blinded to group allocation.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult (≥ 18 years of age)
  • Septic shock according to the Sepsis 3 criteria at any time within 12 hours after ICU admission (suspected or confirmed infection, plasma lactate above 2 mmol/L, and infusion of vasopressor/inotrope to maintain mean arterial pressure of 65mmHg or above after receiving adequate fluid resuscitation [> 1L within 12 h of screening]) and need for vasopressors at the time of screening.

排除标准

  • Confirmed or suspected pregnancy
  • Previous inclusion in the trial
  • Screened more than 12 hours after ICU admission

研究组 & 干预措施

Usual Care

Other

Participants receive non-resuscitation fluids according to local routines.

干预措施: Usual care (Other)

Protocolised reduction of non-resuscitation fluids

Experimental

Participants receive non-resuscitation fluids according to a pre-defined protocol starting within two hours of randomization. The intervention is continued for the duration of the ICU admission up to a maximum of 90 days.

干预措施: Protocolised reduction of non-resuscitation fluids (Other)

结局指标

主要结局

Mortality

时间窗: 90 days after inclusion

All-cause mortality

次要结局

  • Health-Related Quality of Life(6 months after inclusion)
  • Complications in the ICU(From inclusion until final discharge from ICU or death, whichever comes first, assessed up to 90 days)
  • Mechanical ventilation-free days(Within 90 days after inclusion)
  • Cognitive function(6 months after inclusion)

研究者

发起方
Region Skane
申办方类型
Other
责任方
Sponsor

研究点 (28)

Loading locations...

相似试验